May 11, 2012
The Financial Burden of Eye Disease
Ellen Troyer, MT MA Biosyntrx CEO/Chief Research Officer May 11, 2012 The National Eye Institute (NEI) estimates that the current annual cost of vision impairment and degenerative eye disease to the United States private and public sector exceeds $68 billion. And this number does not fully quantify the impact of lost productivity, diminished quality of […]